title: NeuroProtective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury.
abstract: Ischemic brain injury is a leading cause of sever neurological and neurobehavioral deficits and death. The hippocampus plays vital roles in learning and memory processes and it is impaired by ischemic insults. Cerebral ischemia/reperfusion leads to Oxidative stress damage impairing the hippocampus. Here we tested whether ascorbic acid and adenosine receptor played a neuroprotective role in a mouse brain ischemia model induced by common carotid arteries occlusion. Adult male mice were randomly assigned into nine experimental groups. The animals were subjected to ischemia by the ligation of common carotid arteries for 15 min. Drugs were injected intrapritoneally once daily for 7 days. Behavioral tests performed at day 14 and then mice were killed at day 21 and their brains were fixed for microscopic studies and some samples were prepared for western blot analysis. Western blot analysis utilized to evaluate the expression of apoptosis-related proteinsin the hippocampus. Short-term memory was assessed by shuttle-box test. Our findings revealed that administration of vitamin C and N6-cyclopentyladenosine (CPA) significantly attenuated ischemia-induced brain injury. Vitamin C and CPA administration increased the expression of anti-apoptotic protein Bcl-2 and decreased the expression of pro-apoptotic protein Bax in the ischemic mice. Ischemia caused short-term memory loss that was improved by vitamin c and CPA treatment. Our results demonstrate that treatment with vitamin C and adenosine receptor agonist attenuated cerebral ischemia/reperfusion-induced brain injury as a potential neuroprotective agent.
authors: Cellular and Molecular Research Center and Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran.
authors: M
authors: M
authors: Zamani
authors: M
authors: M
authors: Soleimani
authors: F
authors: F
authors: Golab
authors: F
authors: F
authors: Mohamadzadeh
authors: M
authors: M
authors: Mehdizadeh
authors: M
authors: M
authors: Katebi
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D058907:Adenosine A1 Receptor Agonists / Q000494:pharmacology; D058916:Adenosine A1 Receptor Antagonists / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D015153:Blotting, Western; D056547:CA1 Region, Hippocampal / Q000473:pathology*; D020287:In Situ Nick-End Labeling; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008570:Memory, Short-Term / Q000187:drug effects; D051379:Mice; D018696:Neuroprotective Agents; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D018047:Receptors, Purinergic P1 / Q000187:drug effects*; D015427:Reperfusion Injury / Q000473:pathology* / Q000517:prevention & control*; D014970:Xanthines / Q000494:pharmacology; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D058907:Adenosine A1 Receptor Agonists; D058916:Adenosine A1 Receptor Antagonists; D000975:Antioxidants; D018696:Neuroprotective Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D018047:Receptors, Purinergic P1; D014970:Xanthines; D051028:bcl-2-Associated X Protein; C048599:N(6)-cyclopentyladenosine; C051360:1,3-dipropyl-8-cyclopentylxanthine; D000241:Adenosine; D001205:Ascorbic Acid
references: Gastroenterology. 2001 Apr;120(5):1251-62
references: 11266388
references: Clin Interv Aging. 2007;2(1):147-51
references: 18044087
references: Nat Med. 2005 Dec;11(12):1322-9
references: 16286924
references: Neurochem Res. 2012 Mar;37(3):538-47
references: 22071908
references: NeuroRehabilitation. 2010;26(1):47-63
references: 20130355
references: Stroke. 2008 Dec;39(12):3303-7
references: 18845806
references: Purinergic Signal. 2005 Jun;1(2):111-34
references: 18404497
references: Br J Pharmacol. 1996 Jul;118(6):1551-7
references: 8832085
references: Brain Res. 2012 Jun 12;1459:81-90
references: 22560096
references: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9407-12
references: 11470917
references: Brain Res. 1994 Apr 4;641(2):217-24
references: 8012824
references: Nat Med. 1999 May;5(5):554-9
references: 10229233
references: Neurochem Res. 2002 Sep;27(9):911-8
references: 12396102
references: Neurochem Res. 2011 Dec;36(12):2352-62
references: 21850487
references: Acta Neurochir (Wien). 1993;123(1-2):87-91
references: 8213284
references: Biofactors. 2005;24(1-4):265-74
references: 16403987
references: Brain Res. 2012 Sep 20;1474:73-81
references: 22842526
references: Trends Pharmacol Sci. 1992 Dec;13(12):439-45
references: 1293870
references: Learn Mem. 2007 Aug 03;14(8):525-32
references: 17686946
references: Antioxid Redox Signal. 2011 Oct 15;15(8):2221-34
references: 21126189
references: J Neurochem. 2008 Feb;104(3):611-23
references: 17953667
references: Natl Vital Stat Rep. 2011 Aug 26;59(8):1-95
references: 21950210
references: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11720-4
references: 11573006
references: Stroke. 2004 Apr;35(4):987-91
references: 14988572
references: N Engl J Med. 2006 Feb 9;354(6):588-600
references: 16467546
references: Cell Calcium. 2004 Sep-Oct;36(3-4):331-40
references: 15261489
references: Brain Dev. 2009 Apr;31(4):307-17
references: 18682317
references: Brain Res. 2012 Apr 23;1450:116-24
references: 22410291
references: Am J Physiol Renal Physiol. 2012 Sep;303(5):F721-32
references: 22759398
references: Cell Death Differ. 2007 Jul;14(7):1315-23
references: 17396131
references: Cell Death Differ. 2005 Jul;12(7):761-72
references: 15818410
references: J Neurochem. 2006 Jun;97(5):1357-68
references: 16696848
references: Toxicol Sci. 2004 Jul;80(1):69-73
references: 15071173
references: Metab Brain Dis. 2012 Dec;27(4):495-505
references: 22843383
references: J Cereb Blood Flow Metab. 2001 Jan;21(1):2-14
references: 11149664
references: Liver Transpl. 2008 Jun;14(6):845-54
references: 18324658
references: J Cereb Blood Flow Metab. 2011 Feb;31(2):467-75
references: 20648037
references: BMC Neurol. 2011 Mar 30;11:39
references: 21447190
references: Free Radic Biol Med. 2009 Mar 15;46(6):719-30
references: 19162177
references: J Pharmacol Exp Ther. 2000 Aug;294(2):770-7
references: 10900259
references: Neuroscience. 2002;114(3):547-56
references: 12220558
references: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Mar;32(3):390-3
references: 22686090
references: Hippocampus. 2006;16(10):814-25
references: 16892187
references: Hepatology. 2002 Apr;35(4):772-8
references: 11915022
references: Free Radic Biol Med. 2005 Jul 1;39(1):51-70
references: 15925278
references: Free Radic Biol Med. 2006 Feb 15;40(4):617-24
references: 16458192
references: Stroke. 1997 May;28(5):1073-80; discussion 1080-1
references: 9158652
references: J Neurosci. 1999 Jun 1;19(11):4200-10
references: 10341224
references: Am J Public Health. 2005 Nov;95(11):1964-9
references: 16254230
references: Free Radic Biol Med. 2005 Jun 1;38(11):1433-44
references: 15890617
references: Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):204-9
references: 2554151
references: Neurosurgery. 2006 Aug;59(2):383-8; discussion 383-8
references: 16883179
references: J Perinatol. 2009 Jun;29(6):438-43
references: 19242485
references: Biochem Pharmacol. 2006 Oct 30;72(9):1180-95
references: 16997282